75
Participants
Start Date
April 28, 2020
Primary Completion Date
May 3, 2022
Study Completion Date
May 3, 2022
BIIB078
Administered as specified in the treatment arm.
Research Site, Sankt Gallen
Research Site, New York
Research Site, Baltimore
Research Site, Atlanta
Research Site, Jacksonville
Research Site, Miami
Research Site, Knoxville
Research Site, St Louis
Research Site, Lincoln
Research Site, Los Angeles
Research Site, La Jolla
Research Site, Palo Alto
Research Site, Boston
Research Site, Calgary
Research Site, Edmonton
Research Site, Toronto
Research Site, Montreal
Research Site, Utrecht
Research Site, London
Research Site, London
Research Site, Sheffield
Lead Sponsor
Biogen
INDUSTRY